Characteristics of the odontological management of patients with progressive ossifying fibrodyplasia

Aicha Ibourk; Sidi Mohammed Bouzoubaa; Ihsane Ben Yahya

doi:10.1051/mbcb/2019016

Home

All issues

Volume 25 / No 4 (2019)

J Oral Med Oral Surg, 25 4 (2019) 33

References

Open Access

Up-to Date Review And Case Report

Issue		J Oral Med Oral Surg Volume 25, Number 4, 2019


Article Number		33
Number of page(s)		4
Section		Cas clinique et revue de la littérature / Up-to date review and case report
DOI		https://doi.org/10.1051/mbcb/2019016
Published online		12 September 2019

Connor J, Evans D. Fibrodysplasia ossificans progressiva (FOP): the clinical features and natural history of 34 patients. J Bone Joint Surg Br 1982;64:76–83. [CrossRef] [PubMed] [Google Scholar]
Cohen R, Hahn G, Tabas J, Peeper J, Levitz C, Sando A, Sando N, Zasloff M, Kaplan FS. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg 1993;75:215–219. [CrossRef] [PubMed] [Google Scholar]
Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS. Age and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res. 1994;301:243–248. [PubMed] [Google Scholar]
Royce PM, Steinmann B. Connective tissue and its heritable disorders: molecular, genetic, and medical aspects. Am J Hum Genet 2003;72:503–504. [Google Scholar]
Hanisch M, Hanisch L, Fröhlich LF, Werkmeister R, Bohner L, Kleinheinz J. Myositis ossificans traumatica of the masticatory muscles: etiology, diagnosis and treatment. Head Face Med 2018;14:23. [CrossRef] [PubMed] [Google Scholar]
Vashisht R, Prosser D. Anesthesia in a child with fibrodysplasiaossificans progressiva. Paediatr Anaesth 2006;16:684–688. [PubMed] [Google Scholar]
Wentworth KL, Masharani U, Hsiao EC. Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva. Br J Clin Pharmacol 2018. [Google Scholar]
Kilmartin E, Grunwald Z, Kaplan FS, Nussbaum BL. General anesthesia for dental procedures in patients with fibrodysplasia ossificans progressiva: a review of 42 cases in 30 patients. Anesth Analg 2014;118:298–301. [CrossRef] [PubMed] [Google Scholar]
Mori Y, Susami T, Haga N, Tamura K, Kanno Y, Saijo H, Takato T. Extraction of 6 molars under general anesthesia in patient with fibrodysplasia ossificans progressiva. J Oral Maxillofac Surg. 2011;69:1905–1910. [CrossRef] [PubMed] [Google Scholar]
Nussbaum BL, Grunwald Z, Kaplan FS. Oral and dental health care and anesthesia for persons with fibrodysplasiaossificans progressiva. Clin Rev Bone Miner Metab 2005;3:239–242. [Google Scholar]
Trigui M, Ayadi K, Zribi M, Triki Z, Keskes H. Fibrodysplasiaossificans progressiva: diagnosis and surgical management. Acta Orthop Belg. 2011;77:139–144. [PubMed] [Google Scholar]
Roberts T, Stephen L, Scott C, Urban M, Sudi S, Beighton P. Fibrodysplasia ossificans progressiva (FOP) in South Africa: dental implications in 5 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:11–18. [CrossRef] [PubMed] [Google Scholar]
Morales-Piga A, Kaplan FS. Osteochondral diseases and fibrodysplasia ossificans progressiva. Adv Exp Med Biol 2010;686:335–338. [CrossRef] [PubMed] [Google Scholar]
Schoenmaker T, Wouters F, Micha D, Forouzanfar T, Netelenbos C, Eekhoff EMW, Bravenboer N, de Vries TJ. The effect of Activin-A on periodontal ligament fibroblasts-mediated osteoclast formation in healthy donors and in patients with fibrodysplasia ossificans progressiva. J Cell Physiol 2018. [Google Scholar]
Shore EM, Feldman GJ, Xu M, Kaplan FS. The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 2005;3:201–224. [Google Scholar]
Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby R, Kitterman JA, Groppe J, Eileen M. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 2008;22:191–205. [Google Scholar]
Kaplan FS, Shore EM, Pignolo RJ. (eds), name of individual consortium member, and The International Clinical Consortium on FOP. The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Clin Proc Intl Clin Consort FOP 2011;4:1–100. [Google Scholar]
Geddis-Regan A. Severe trismus and contraindicated exodontia in a patient with fibrodysplasia ossificans progressiva: case report. Br J Oral Maxillofac Surg. 2018;56. [PubMed] [Google Scholar]
Young JM, Diecidue RJ, Nussbaum BL. Oral management in a patient with Fibrodysplasia ossificans progressiva. Spec Care Dentist 2007;27:101–114. [CrossRef] [PubMed] [Google Scholar]
Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects. Orphanet J Rare Dis 2011;6:80. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.

[1] Connor J, Evans D. Fibrodysplasia ossificans progressiva (FOP): the clinical features and natural history of 34 patients. J Bone Joint Surg Br 1982;64:76–83. [CrossRef] [PubMed] [Google Scholar]

[2] Cohen R, Hahn G, Tabas J, Peeper J, Levitz C, Sando A, Sando N, Zasloff M, Kaplan FS. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg 1993;75:215–219. [CrossRef] [PubMed] [Google Scholar]

[3] Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS. Age and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res. 1994;301:243–248. [PubMed] [Google Scholar]

[4] Royce PM, Steinmann B. Connective tissue and its heritable disorders: molecular, genetic, and medical aspects. Am J Hum Genet 2003;72:503–504. [Google Scholar]

[5] Hanisch M, Hanisch L, Fröhlich LF, Werkmeister R, Bohner L, Kleinheinz J. Myositis ossificans traumatica of the masticatory muscles: etiology, diagnosis and treatment. Head Face Med 2018;14:23. [CrossRef] [PubMed] [Google Scholar]

[6] Vashisht R, Prosser D. Anesthesia in a child with fibrodysplasiaossificans progressiva. Paediatr Anaesth 2006;16:684–688. [PubMed] [Google Scholar]

[7] Wentworth KL, Masharani U, Hsiao EC. Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva. Br J Clin Pharmacol 2018. [Google Scholar]

[8] Kilmartin E, Grunwald Z, Kaplan FS, Nussbaum BL. General anesthesia for dental procedures in patients with fibrodysplasia ossificans progressiva: a review of 42 cases in 30 patients. Anesth Analg 2014;118:298–301. [CrossRef] [PubMed] [Google Scholar]

[9] Mori Y, Susami T, Haga N, Tamura K, Kanno Y, Saijo H, Takato T. Extraction of 6 molars under general anesthesia in patient with fibrodysplasia ossificans progressiva. J Oral Maxillofac Surg. 2011;69:1905–1910. [CrossRef] [PubMed] [Google Scholar]

[10] Nussbaum BL, Grunwald Z, Kaplan FS. Oral and dental health care and anesthesia for persons with fibrodysplasiaossificans progressiva. Clin Rev Bone Miner Metab 2005;3:239–242. [Google Scholar]

[11] Trigui M, Ayadi K, Zribi M, Triki Z, Keskes H. Fibrodysplasiaossificans progressiva: diagnosis and surgical management. Acta Orthop Belg. 2011;77:139–144. [PubMed] [Google Scholar]

[12] Roberts T, Stephen L, Scott C, Urban M, Sudi S, Beighton P. Fibrodysplasia ossificans progressiva (FOP) in South Africa: dental implications in 5 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:11–18. [CrossRef] [PubMed] [Google Scholar]

[13] Morales-Piga A, Kaplan FS. Osteochondral diseases and fibrodysplasia ossificans progressiva. Adv Exp Med Biol 2010;686:335–338. [CrossRef] [PubMed] [Google Scholar]

[14] Schoenmaker T, Wouters F, Micha D, Forouzanfar T, Netelenbos C, Eekhoff EMW, Bravenboer N, de Vries TJ. The effect of Activin-A on periodontal ligament fibroblasts-mediated osteoclast formation in healthy donors and in patients with fibrodysplasia ossificans progressiva. J Cell Physiol 2018. [Google Scholar]

[15] Shore EM, Feldman GJ, Xu M, Kaplan FS. The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 2005;3:201–224. [Google Scholar]

[16] Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby R, Kitterman JA, Groppe J, Eileen M. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 2008;22:191–205. [Google Scholar]

[17] Kaplan FS, Shore EM, Pignolo RJ. (eds), name of individual consortium member, and The International Clinical Consortium on FOP. The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Clin Proc Intl Clin Consort FOP 2011;4:1–100. [Google Scholar]

[18] Geddis-Regan A. Severe trismus and contraindicated exodontia in a patient with fibrodysplasia ossificans progressiva: case report. Br J Oral Maxillofac Surg. 2018;56. [PubMed] [Google Scholar]

[19] Young JM, Diecidue RJ, Nussbaum BL. Oral management in a patient with Fibrodysplasia ossificans progressiva. Spec Care Dentist 2007;27:101–114. [CrossRef] [PubMed] [Google Scholar]

[20] Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects. Orphanet J Rare Dis 2011;6:80. [CrossRef] [PubMed] [Google Scholar]